🇺🇸 ABBV — AbbVie Inc.

Healthcare Compra
← Volver

Precio actual

256,46 USD

Máx. histórico

267,47

37 días

Caída desde máximo

-4,12%

Rango 52 semanas

190,75 – 267,47

Variación hoy

-1,44%

Cierre anterior

260,21

Rango de hoy

255,61 – 258,91

Volumen hoy

4.701.126

Información
Nombre completo
AbbVie Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
57.000
PER ⓘ
72,45 (puede no estar actualizado)
Dividend yield
2,70% (puede no estar actualizado)
Precio objetivo analistas
276,59 USD (puede no estar actualizado)
Primera cotización
02/01/2013
Precio actualizado
hace 1 día
Sobre la empresa

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma; and Emrelis for the treatment of lung cancer. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox Cosmetic for the treatment of glabellar lines, crow's feet, forehead lines, and platysma bands; Juvederm Collection to treat volume loss in the temples, undereye, cheeks, chin, lips and lower face; Vraylar to treat schizophrenia, bipolar disorder, and depressive disorder; Duodopa to treat Parkinson's disease; Ubrelvy to treat migraine; Qulipta for episodic and chronic migraine; and Vyalev for the treatment of motor fluctuations, as well as Botox Therapeutic to treat chronic migraine, overactive bladder, spasticity, cervical dystonia, and other conditions. In addition, the company offers Ozurdex for visual impairment; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; and other eye care products, including Refresh/Optive, Xen, Durysta, and Restasis. Further, it provides Mavyret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Dividendos repartidos Total últimos 12 meses: 6,8300 USD · Yield: 2,66%
Fecha de pago Importe por participación
13/04/2015 0,5100 USD
13/01/2015 0,4900 USD
10/10/2014 0,4200 USD
11/07/2014 0,4200 USD
11/04/2014 0,4200 USD
13/01/2014 0,4000 USD
10/10/2013 0,4000 USD
11/07/2013 0,4000 USD
11/04/2013 0,4000 USD
11/01/2013 0,4000 USD
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
04/11/2022 145,35 145,58 143,08 145,28 +0,60% 1,72% 4.623.700
03/11/2022 144,00 145,42 143,03 144,42 -0,07% 1,66% 3.850.700
02/11/2022 147,03 148,08 144,48 144,52 -1,63% 2,45% 5.345.000
01/11/2022 146,66 147,70 144,55 146,91 +0,35% 2,15% 6.351.200
31/10/2022 145,17 146,78 144,08 146,40 -0,82% 1,86% 8.604.800
28/10/2022 145,93 148,98 142,34 147,61 -3,84% 4,55% 10.812.200
27/10/2022 153,76 153,99 152,06 153,50 +0,65% 1,26% 6.850.400
26/10/2022 151,01 152,89 150,70 152,51 +1,80% 1,45% 4.727.900
25/10/2022 148,03 150,60 147,29 149,82 -0,71% 2,24% 5.229.400
24/10/2022 148,71 151,53 148,70 150,89 +2,60% 1,90% 5.139.700
21/10/2022 143,34 147,76 142,43 147,06 +2,89% 3,72% 5.419.400
20/10/2022 143,16 144,04 142,43 142,93 -0,14% 1,12% 3.880.100
19/10/2022 144,80 145,45 142,31 143,13 -1,02% 2,17% 3.333.300
18/10/2022 145,23 145,87 143,53 144,60 +0,13% 1,61% 3.540.400
17/10/2022 142,65 144,93 142,10 144,41 +1,03% 1,98% 4.016.200
14/10/2022 142,60 144,48 142,21 142,94 +0,01% 1,59% 5.290.500
13/10/2022 136,70 143,18 136,27 142,92 +2,10% 5,05% 5.066.200
12/10/2022 141,64 143,06 139,93 139,98 -1,08% 2,21% 4.528.000
11/10/2022 138,02 143,68 138,02 141,51 +2,31% 4,10% 5.675.100
10/10/2022 139,03 139,59 136,87 138,31 -0,32% 1,96% 3.830.800
07/10/2022 139,01 140,05 137,55 138,76 -1,09% 1,80% 4.648.800
06/10/2022 142,79 142,99 139,90 140,29 -2,12% 2,16% 5.124.800
05/10/2022 141,47 144,47 141,11 143,33 +0,94% 2,38% 4.777.900
04/10/2022 139,21 142,72 137,76 141,99 +2,65% 3,56% 6.612.300
03/10/2022 135,88 138,80 135,31 138,32 +3,06% 2,57% 7.437.500
30/09/2022 142,20 142,32 134,09 134,21 -5,96% 5,79% 15.359.000
29/09/2022 144,85 145,25 141,83 142,72 -1,30% 2,36% 5.509.400
28/09/2022 144,22 145,32 142,62 144,60 +2,03% 1,87% 5.226.700
27/09/2022 142,59 145,54 141,29 141,72 +0,36% 2,98% 5.598.000
26/09/2022 142,08 142,80 140,11 141,21 -1,29% 1,89% 5.697.800